Akebia Therapeutics
AKBA
#9606
Rank
S$0.13 B
Marketcap
S$0.50
Share price
-8.71%
Change (1 day)
-76.08%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): S-$0.21

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.21. In 2025 the company made an earnings per share (EPS) of S-$0.02580 an increase over its 2024 EPS that were of S-$0.43.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.21696.29%
2025S-$0.02580-93.94%
2024S-$0.43-16.83%
2023S-$0.51-23.7%
2022S-$0.67-69.41%
2021S-$2.19-38.63%
2020S-$3.5717.37%
2019S-$3.042.79%
2018S-$2.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$22.42-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$8.64 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA